Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Pang
S Y
SY
Department of Pediatrics, College of Medicine, University of Illinois, Chicago 60612.
Pollack
M S
MS
Marshall
R N
RN
Immken
L
L
D019326:17-alpha-Hydroxyprogesterone; D000284:Administration, Oral; D000312:Adrenal Hyperplasia, Congenital / Q000188:drug therapy*; D000328:Adult; D000653:Amniotic Fluid / Q000032:analysis; D000728:Androgens / Q000032:analysis; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005315:Fetal Diseases / Q000188:drug therapy*; D005836:Genitalia, Female / Q000002:abnormalities; D005865:Gestational Age; D006801:Humans; D006908:Hydroxyprogesterones / Q000032:analysis; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D013250:Steroid Hydroxylases / Q000172:deficiency*; D014770:Virilism / Q000517:prevention & control
D000728:Androgens; D006908:Hydroxyprogesterones; D019326:17-alpha-Hydroxyprogesterone; D003907:Dexamethasone; D013250:Steroid Hydroxylases